Annual EBITDA:
-$492.89M-$312.91M(-173.87%)Summary
- As of today, DNLI annual EBITDA is -$492.89 million, with the most recent change of -$312.91 million (-173.87%) on December 31, 2024.
- During the last 3 years, DNLI annual EBITDA has fallen by -$205.73 million (-71.64%).
- DNLI annual EBITDA is now -791.78% below its all-time high of $71.25 million, reached on December 31, 2020.
Performance
DNLI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$131.92M+$11.34M(+7.91%)Summary
- As of today, DNLI quarterly EBITDA is -$131.92 million, with the most recent change of +$11.34 million (+7.91%) on June 30, 2025.
- Over the past year, DNLI quarterly EBITDA has dropped by -$17.27 million (-15.06%).
- DNLI quarterly EBITDA is now -153.73% below its all-time high of $245.51 million, reached on December 31, 2020.
Performance
DNLI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$524.51M-$17.27M(-3.40%)Summary
- As of today, DNLI TTM EBITDA is -$524.51 million, with the most recent change of -$17.27 million (-3.40%) on June 30, 2025.
- Over the past year, DNLI TTM EBITDA has dropped by -$37.80 million (-7.77%).
- DNLI TTM EBITDA is now -850.73% below its all-time high of $69.87 million, reached on December 31, 2020.
Performance
DNLI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DNLI EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -173.9% | -15.1% | -7.8% |
| 3Y3 Years | -71.6% | -119.2% | -83.8% |
| 5Y5 Years | -140.2% | -123.1% | -126.7% |
DNLI EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -173.9% | at low | -176.8% | +7.9% | -254.1% | at low |
| 5Y | 5-Year | -791.8% | at low | -153.7% | +7.9% | -850.7% | at low |
| All-Time | All-Time | -791.8% | at low | -153.7% | +7.9% | -850.7% | at low |
DNLI EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$131.92M(+7.9%) | -$524.51M(-3.4%) |
| Mar 2025 | - | -$143.25M(-11.9%) | -$507.25M(-2.7%) |
| Dec 2024 | -$492.89M(-173.9%) | -$127.99M(-5.5%) | -$494.08M(+0.5%) |
| Sep 2024 | - | -$121.35M(-5.8%) | -$496.49M(-2.0%) |
| Jun 2024 | - | -$114.65M(+11.9%) | -$486.71M(-143.1%) |
| Mar 2024 | - | -$130.09M(+0.2%) | -$200.22M(-10.1%) |
| Dec 2023 | -$179.97M(+45.5%) | -$130.40M(-16.9%) | -$181.78M(-18.4%) |
| Sep 2023 | - | -$111.58M(-164.9%) | -$153.50M(-3.6%) |
| Jun 2023 | - | $171.84M(+253.9%) | -$148.13M(+61.0%) |
| Mar 2023 | - | -$111.64M(-9.3%) | -$380.15M(-13.9%) |
| Dec 2022 | -$330.36M(-15.0%) | -$102.12M(+3.9%) | -$333.71M(-8.6%) |
| Sep 2022 | - | -$106.21M(-76.5%) | -$307.41M(-7.7%) |
| Jun 2022 | - | -$60.18M(+7.7%) | -$285.38M(+0.1%) |
| Mar 2022 | - | -$65.20M(+14.0%) | -$285.54M(+1.6%) |
| Dec 2021 | -$287.16M | -$75.81M(+10.0%) | -$290.14M(-1030.7%) |
| Sep 2021 | - | -$84.19M(-39.5%) | $31.18M(-45.0%) |
| Jun 2021 | - | -$60.34M(+13.6%) | $56.71M(-2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$69.80M(-128.4%) | $57.92M(-17.1%) |
| Dec 2020 | $71.25M(+134.7%) | $245.51M(+518.6%) | $69.87M(+130.2%) |
| Sep 2020 | - | -$58.65M(+0.8%) | -$231.34M(-4.7%) |
| Jun 2020 | - | -$59.13M(-2.2%) | -$220.96M(+0.1%) |
| Mar 2020 | - | -$57.86M(-3.9%) | -$221.15M(-8.7%) |
| Dec 2019 | -$205.19M(-426.7%) | -$55.70M(-15.4%) | -$203.39M(-188.1%) |
| Sep 2019 | - | -$48.27M(+18.6%) | -$70.59M(-21.8%) |
| Jun 2019 | - | -$59.32M(-47.9%) | -$57.96M(-24.3%) |
| Mar 2019 | - | -$40.10M(-152.0%) | -$46.63M(-48.4%) |
| Dec 2018 | -$38.96M(+55.3%) | $77.10M(+316.4%) | -$31.41M(+76.1%) |
| Sep 2018 | - | -$35.64M(+25.7%) | -$131.25M(-12.1%) |
| Jun 2018 | - | -$47.98M(-92.8%) | -$117.12M(-69.4%) |
| Mar 2018 | - | -$24.89M(-9.5%) | -$69.14M(-56.3%) |
| Dec 2017 | -$87.06M(-1.3%) | -$22.73M(-5.7%) | -$44.24M(-9.0%) |
| Sep 2017 | - | -$21.51M(-12.7%) | -$40.60M(+18.2%) |
| Dec 2016 | -$85.96M(-419.2%) | -$19.09M(+37.5%) | -$49.62M(-62.5%) |
| Sep 2016 | - | -$30.53M | -$30.53M |
| Dec 2015 | -$16.56M | - | - |
FAQ
- What is Denali Therapeutics Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. annual EBITDA year-on-year change?
- What is Denali Therapeutics Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. quarterly EBITDA year-on-year change?
- What is Denali Therapeutics Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. TTM EBITDA year-on-year change?
What is Denali Therapeutics Inc. annual EBITDA?
The current annual EBITDA of DNLI is -$492.89M
What is the all-time high annual EBITDA for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high annual EBITDA is $71.25M
What is Denali Therapeutics Inc. annual EBITDA year-on-year change?
Over the past year, DNLI annual EBITDA has changed by -$312.91M (-173.87%)
What is Denali Therapeutics Inc. quarterly EBITDA?
The current quarterly EBITDA of DNLI is -$131.92M
What is the all-time high quarterly EBITDA for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high quarterly EBITDA is $245.51M
What is Denali Therapeutics Inc. quarterly EBITDA year-on-year change?
Over the past year, DNLI quarterly EBITDA has changed by -$17.27M (-15.06%)
What is Denali Therapeutics Inc. TTM EBITDA?
The current TTM EBITDA of DNLI is -$524.51M
What is the all-time high TTM EBITDA for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high TTM EBITDA is $69.87M
What is Denali Therapeutics Inc. TTM EBITDA year-on-year change?
Over the past year, DNLI TTM EBITDA has changed by -$37.80M (-7.77%)